Search results for: 'China Cell and Gene Therapy Industry Development White Pape'

With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

Organic solar cells (OSCs) are emerging as one of the more versatile photovoltaic technologies inthe third-generation solar cell technology domain, owing to their unique characteristics of flexibility, ultralightweight form factors, low-temperature processing, and compatibility with high-throughput printing techniques. Advancements in donor–accepto...

With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

Energy decentralization, supportive regulations and policies, greater focus on sustainability, and the crucial development of a hydrogen economy will drive stationary fuel cell industry growth during the next decade. The wider market for decentralized energy solutions is thriving as residential, commercial, and industrial customers look to achieve ...

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...